local resection
Showing 1 - 25 of >10,000
Chemo Effect, Rectal Cancer Trial in Guangzhou (Radical total mesorectal excision, Salavge Adjuvant Chemoradiotherapy)
Recruiting
- Chemotherapy Effect
- Rectal Cancer
- Radical total mesorectal excision
- Salavge Adjuvant Chemoradiotherapy
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Sep 12, 2023
Gastrointestinal Stromal Tumor of Rectum Trial in Fuzhou (Imatinib Mesylate, Local resection)
Not yet recruiting
- Gastrointestinal Stromal Tumor of Rectum
- Imatinib Mesylate
- Local resection
-
Fuzhou, Fujian, ChinaWeizhong Jiang
Jul 23, 2023
Imatinib With Hepatic Resection or Other Local Treatment for
Completed
- GIST, Malignant
- Liver Metastases
- imatinib (IM)
- +3 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Sep 12, 2023
Colonic Tumors Malignant, Cecal Tumors Trial in Moscow (ileocecal resection with extended D3 lymphadenectomy., Right
Recruiting
- Colonic Neoplasms Malignant
- Cecal Neoplasms
- ileocecal resection with extended D3 lymphadenectomy.
- Right hemicolectomy with D3 lymphadenectomy.
-
Moscow, Russian FederationMoscow Clinical Scientific Center
Nov 5, 2023
Status of Surgical Resection and Histologic Subtype as
Completed
- Liposarcoma of Soft Tissue
- Surgical Procedure, Unspecified
- Retroperitoneal Liposarcoma resection
-
São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina da Universidade d
Jun 18, 2022
Esophageal Tumors Trial in Dresden (Povidone-Iodine)
Completed
- Esophageal Neoplasms
-
Dresden, GermanyDepartment of GI, Thoracic and Vascular Surgery, University Hosp
Jul 13, 2022
PDAC, Pancreatoduodenectomy, Margin, Resection Trial in Duesseldorf (oncological relevance of the mesopancreas)
Not yet recruiting
- PDAC
- +4 more
- oncological relevance of the mesopancreas
-
Duesseldorf, GermanyUniversity Hospital Duesseldorf, Heinrich Heine University
May 30, 2023
Pancreas Adenocarcinoma Trial in Leiden (Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101)
Not yet recruiting
- Pancreas Adenocarcinoma
- Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101
-
Leiden, NetherlandsLeiden University Medical Center
Aug 2, 2023
Hepatic Resection, Acute Pain, Anesthesia Trial in San Diego (0.2% ropivacaine local anesthetic continuous erector spinae plane
Recruiting
- Hepatic Resection
- +3 more
- 0.2% ropivacaine local anesthetic continuous erector spinae plane block
- +2 more
-
San Diego, CaliforniaUniversity of California, San Diego
Jun 6, 2022
Colorectal Cancer, Recurrence, Local Tumor Trial in Coimbra (WLE followed by NBI or NBI followed by WLE (crossover design))
Completed
- Colorectal Cancer
- Recurrence, Local Neoplasm
- WLE followed by NBI or NBI followed by WLE (crossover design)
-
Coimbra, PortugalPortuguese Oncology Institute - Coimbra
Oct 3, 2022
Patients Receiving Hepatectomy Under General Anesthesia Trial in Seoul (Percutaneous injection, Morphine, Morphine+Bupivacaine)
Completed
- Patients Receiving Hepatectomy Under General Anesthesia
- Percutaneous injection
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jan 12, 2022
Treatments for Brain Metastases With Poor Prognostic Factors
Enrolling by invitation
- Brain Metastases
- neurosurgical resection
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Dec 13, 2022
Glioblastoma Trial in Sacramento (Biospecimen Collection, Lidocaine, Resection)
Active, not recruiting
- Glioblastoma
- Biospecimen Collection
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Jan 21, 2022
Melanoma Trial in Fort Wayne, Barcelona (Nivolumab/rHuPH20, Nivolumab)
Recruiting
- Melanoma
- Nivolumab/rHuPH20
- Nivolumab
-
Fort Wayne, Indiana
- +1 more
May 10, 2022
Melanoma Trial in Worldwide (Nivolumab, Nivolumab + Relatlimab Fixed Dose Combination)
Recruiting
- Melanoma
- Nivolumab
- Nivolumab + Relatlimab Fixed Dose Combination
-
Birmingham, Alabama
- +185 more
Dec 3, 2022
Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)
Recruiting
- Adenocarcinoma
- +8 more
- Radiotherapy targeted to the primary lesion
- +7 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 7, 2023
NSCLC Trial in Worldwide (Nivolumab, Carboplatin, Cisplatin)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Nivolumab
- +6 more
-
Tampa, Florida
- +112 more
Jan 30, 2023
Paranasal Sinus Cancer, Nasal Cavity Tumor, Nasal Cavity Adenocarcinoma Trial in United States (drug, radiation, procedure)
Completed
- Paranasal Sinus Cancer
- +2 more
- Cisplatin
- +3 more
-
Basking Ridge, New Jersey
- +4 more
Jan 17, 2023
Bladder Cancer Trial in Moscow (en bloc resection, morcellation, piecemeal resection, tissue removal by loop)
Unknown status
- Bladder Cancer
- en bloc resection, morcellation
- piecemeal resection, tissue removal by loop
-
Moscow, Russian FederationInstitute for Urology and Reproductive Health, Sechenov Universi
Feb 19, 2021
NSCLC, Stage IV, Oligometastasis Trial in Netherlands, Spain, Switzerland (drug, radiation, procedure)
Active, not recruiting
- Non-small Cell Lung Cancer
- +2 more
- Durvalumab
- +6 more
-
Milano, Italy
- +12 more
Dec 14, 2022
Circumferential Resection Margin, Intraoperative Perforation of Rectum, Local Recurrence of Malignant Tumor of Rectum Trial in
Recruiting
- Circumferential Resection Margin
- +4 more
- neoadjuvant chemoradiotherapy
-
Beijing, Beijing, ChinaBeijing Chaoyang Hospital
Feb 4, 2021
Upper Tracheal Resection, Tracheal Reconstruction Surgery Trial (Superficial cervical plexus block, Local wound infiltration)
Withdrawn
- Upper Tracheal Resection
- Tracheal Reconstruction Surgery
- Superficial cervical plexus block
- Local wound infiltration
- (no location specified)
Sep 9, 2020